# 01 — Preoperative Assessment & Checklist  
### Post-Mastectomy Breast Implant Revision  
### Multimodal Anesthesia & Surgical Workflow Protocol  

**Version 1.0 — December 2025**  
[![License: CC BY 4.0](https://img.shields.io/badge/License-CC%20BY%204.0-lightgrey.svg)](https://creativecommons.org/licenses/by/4.0/)

---

## Purpose
Structured, evidence-informed preoperative assessment integrating surgical, anesthesia, oncologic, and infection-risk evaluation for **post-mastectomy implant revision surgery**.

Designed for anesthesia trainees, CRNAs, plastic surgery residents, and perioperative teams.

---

## 1. Patient Identification & Background

### 1.1 Demographics
- **Name**: ____________________  
- **Age**: ______ years  
- **BMI**: ______ kg/m²  

### 1.2 Primary Surgical Indication *(select all that apply)*
- [ ] Bilateral mastectomy (prior)  
- [ ] Implant malposition  
- [ ] Capsular contracture (Baker Grade III–IV)  
- [ ] Suspected or confirmed infection  
- [ ] Implant rupture (silicone extravasation)  
- [ ] Chronic/recurrent seroma  
- [ ] Aesthetic size or style change  
- [ ] Pocket revision for symmetry  
- [ ] BIA-ALCL concern or workup  

### 1.3 Relevant Comorbidities
- [ ] Hypertension  
- [ ] Diabetes mellitus  
- [ ] GERD / reflux  
- [ ] Coronary artery disease / CHF  
- [ ] Asthma / COPD  
- [ ] Chronic kidney disease  
- [ ] Obesity (BMI ≥ 35)  
- [ ] Coagulopathy or therapeutic anticoagulation  
- [ ] Anxiety / psychiatric illness  
- [ ] Chronic opioid use (>3 months)  

**ASA Physical Status**: [ ] I  [ ] II  [ ] III  [ ] IV

---

## 2. Oncologic & Prior Reconstruction History

### 2.1 Cancer Treatment
- Year of mastectomy: ______  
- Prior radiation therapy: [ ] Yes  [ ] No  
- Prior chemotherapy: [ ] Yes  [ ] No  

### 2.2 Previous Reconstruction
- Type: [ ] Direct-to-implant  [ ] Tissue expander → implant  [ ] Autologous  
- Implant: [ ] Silicone  [ ] Saline  [ ] Unknown  
- Pocket plane: [ ] Prepectoral  [ ] Subpectoral  [ ] Dual-plane  

### 2.3 Prior Complications
- [ ] Infection  [ ] Seroma  [ ] Hematoma  [ ] Capsular contracture  
- [ ] Wound dehiscence  [ ] ADM exposure/failure  [ ] Implant extrusion

---

## 3. Infection Risk Stratification
**Current signs/symptoms**  
- [ ] Fever  [ ] Erythema  [ ] Purulent drainage  [ ] Warmth  
- [ ] Pain out of proportion  [ ] Recent antibiotics  [ ] Elevated WBC  

→ **If infection suspected**: plan intraoperative cultures + extended antibiotic coverage

---

## 4. Laboratory & Imaging Review
**Required**  
- [ ] CBC  [ ] CMP  [ ] Coagulation profile (if indicated)  
- [ ] Pregnancy test (premenopausal)  [ ] HbA1c (if diabetic)  

**As indicated**  
- [ ] Breast MRI/ultrasound (rupture evaluation)  
- [ ] Prior operative reports reviewed  
- [ ] Previous culture data available

---

## 5. Airway & Anesthesia-Specific Evaluation

### 5.1 Airway Exam
- Mallampati: [ ] I  [ ] II  [ ] III  [ ] IV  
- Thyromental distance: ______ cm  
- Inter-incisor distance: ______ cm  
- Neck extension limited: [ ] Yes  [ ] No  
- History of difficult airway: [ ] Yes  [ ] No  

### 5.2 PONV Risk (Apfel Score)
- [ ] Female sex (+1)  
- [ ] Non-smoker (+1)  
- [ ] History of PONV/motion sickness (+1)  
- [ ] Postoperative opioids expected (+1)  

**Total score**: ______ / 4  →  [ ] Low  [ ] Moderate  [ ] High (≥3)

### 5.3 Hemodynamic Notes
- [ ] On chronic beta-blocker (caution with dexmedetomidine bolus)  
- [ ] Baseline bradycardia (HR <50)  
- [ ] Poorly controlled hypertension

---

## 6. Regional Anesthesia Eligibility (PECS I/II or Serratus Plane Block)

### 6.1 Absolute/Relative Contraindications
- [ ] Local infection at block site  
- [ ] Coagulopathy or therapeutic anticoagulation  
- [ ] Patient refusal  
- [ ] Severe respiratory compromise  
- [ ] Allergy to local anesthetics  

### 6.2 Planned Regional Technique
- [ ] PECS I + II blocks  
- [ ] Serratus anterior plane block  
- [ ] No block planned (patient preference or contraindicated)

---

## 7. Selected Anesthesia Pathway
| Pathway | Selection |
|-------|-----------|
| **1** — Opioid-Free GA + Regional Block (Preferred) | [ ] |
| **2** — Opioid-Free GA, No Block (IV multimodal only) | [ ] |
| **3** — Conventional Opioid-Based GA (Fallback) | [ ] |

---

## 8. Perioperative Medication Plan

### 8.1 Premedication / Multimodal Analgesia
- [ ] Acetaminophen 1000 mg PO  
- [ ] Gabapentin 300–600 mg PO (or pregabalin 150 mg)  
- [ ] Celecoxib 200–400 mg PO (if no contraindication)  

### 8.2 Antibiotic Prophylaxis
- [ ] Cefazolin 2–3 g IV (weight-based)  
- [ ] Vancomycin or Clindamycin (penicillin allergy)  

---

## 9. Final Preoperative Checklist (Day of Surgery)
- [ ] Patient identity confirmed (two identifiers)  
- [ ] Surgical consent + implant consent signed  
- [ ] Site marked & laterality confirmed  
- [ ] Antibiotics administered (<60 min pre-incision)  
- [ ] Premedications given  
- [ ] Regional block performed (if planned)  
- [ ] Implants/sizers available in OR  
- [ ] Airway equipment & difficult airway cart confirmed  

---

## 10. Team Huddle / Brief
**Key topics to confirm verbally before incision:**
- Laterality & planned procedure  
- Use of drains / postoperative garment  
- Regional block performed?  
- Anesthesia pathway & PONV prophylaxis  
- Anticipated challenges (scarring, fibrosis, infection)  
- Communication plan for hemodynamics & pain

---

**End of Preoperative Assessment**  
*Educational resource only — adapt to institutional protocols and clinical judgment.*

---
